The final coverage decision specifies the questions that studies must address and the standards those studies must meet for Medicare coverage. In developing this policy, CMS consulted with the Agency for Healthcare Research and Quality, and both agencies believe the questions and standards meet the requirements of the Medicare statute. CMS will accept submissions from the research community about trials that may answer CMS' questions about artificial hearts. Clinical studies that are determined to meet CMS' requirements will be listed on the CMS website.
"Our policy will allow beneficiaries to access artificial heart technology while also stimulating the research community to develop further evidence about the impact of this technology on improving patient outcomes," Weems said.
Ad Statistics
Times Displayed: 45539
Times Visited: 1299 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
The final coverage policy issued today follows a proposed decision issued in February 2008. Public comments received in response to the proposed decision were generally supportive of this decision. The final decision memorandum is available on the CMS Web site at http://www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=211.
Back to HCB News
